These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2679798)

  • 1. Leishmania infection: surfaces and immunity.
    Wright EP; el Amin ER
    Biochem Cell Biol; 1989 Sep; 67(9):525-36. PubMed ID: 2679798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell biology of host-parasite membrane interactions in leishmaniasis.
    Chang KP; Fong D
    Ciba Found Symp; 1983; 99():113-37. PubMed ID: 6357669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage-parasite interactions in Leishmania infections.
    Mauël J
    J Leukoc Biol; 1990 Feb; 47(2):187-93. PubMed ID: 2406358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania and the macrophage: a multifaceted interaction.
    Podinovskaia M; Descoteaux A
    Future Microbiol; 2015; 10(1):111-29. PubMed ID: 25598341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E; Lang T; Glaichenhaus N; Antoine JC
    J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface determinants of Leishmania parasites and their role in infectivity in the mammalian host.
    Naderer T; Vince JE; McConville MJ
    Curr Mol Med; 2004 Sep; 4(6):649-65. PubMed ID: 15357214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity.
    Chang KP; Reed SG; McGwire BS; Soong L
    Acta Trop; 2003 Mar; 85(3):375-90. PubMed ID: 12659975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parasitic adaptive mechanisms in infection by leishmania.
    Cunningham AC
    Exp Mol Pathol; 2002 Apr; 72(2):132-41. PubMed ID: 11890722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The macrophage-attachment glycoprotein gp63 is the predominant C3-acceptor site on Leishmania mexicana promastigotes.
    Russell DG
    Eur J Biochem; 1987 Apr; 164(1):213-21. PubMed ID: 3549304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of the major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages.
    Russell DG; Wilhelm H
    J Immunol; 1986 Apr; 136(7):2613-20. PubMed ID: 3950420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmaniasis and glycosaminoglycans: a future therapeutic strategy?
    Merida-de-Barros DA; Chaves SP; Belmiro CLR; Wanderley JLM
    Parasit Vectors; 2018 Oct; 11(1):536. PubMed ID: 30285837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro phagocytosis of Leishmania (Leishmania) amazonensis promastigotes by B-1 cells.
    Geraldo MM; Costa CR; Barbosa FM; Vivanco BC; Gonzaga WF; Novaes E Brito RR; Popi AF; Lopes JD; Xander P
    Parasite Immunol; 2016 Jun; 38(6):365-76. PubMed ID: 27084328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Leishmania antigen on the surface membrane of infected human macrophages in vitro.
    Berman JD; Dwyer DM
    Clin Exp Immunol; 1981 May; 44(2):342-8. PubMed ID: 7030533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
    Mosser DM; Edelson PJ
    J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of metacyclic Leishmania promastigotes is associated with the increasing expression of GP65, the major surface antigen.
    Kweider M; Lemesre JL; Santoro F; Kusnierz JP; Sadigursky M; Capron A
    Parasite Immunol; 1989 May; 11(3):197-209. PubMed ID: 2771426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania, macrophages and complement: a tale of subversion and exploitation.
    Mosser DM; Brittingham A
    Parasitology; 1997; 115 Suppl():S9-23. PubMed ID: 9571687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-mediated lysis and infectivity for mouse macrophages and sandflies of virulent and attenuated Leishmania major promastigotes varying in expression of the major surface protease and lipophosphoglycan.
    Camara M; Ortiz G; Valero PL; Molina R; Navarro I; Chance ML; Segovia M
    Ann Trop Med Parasitol; 1995 Jun; 89(3):243-51. PubMed ID: 7668915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early mechanisms of Leishmania infection in human blood.
    Domínguez M; Moreno I; Aizpurua C; Toraño A
    Microbes Infect; 2003 May; 5(6):507-13. PubMed ID: 12758280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-mediated phagocytosis of Leishmania: implications for intracellular survival.
    Ueno N; Wilson ME
    Trends Parasitol; 2012 Aug; 28(8):335-44. PubMed ID: 22726697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of Leishmania with the host macrophage.
    Handman E; Bullen DV
    Trends Parasitol; 2002 Aug; 18(8):332-4. PubMed ID: 12377273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.